Agent | Mechanism | Cells | Animals | Administered dose | References | |
---|---|---|---|---|---|---|
In vitro | In vivo | |||||
Citropten | Inhibited MAPK and PLCγ/Ca2+ signaling pathways | RAW264.7 cell | N/A | 5–40 μM | N/A | Trang et al. (2023) |
βBA | Inhibited the phosphorylation of Btk and PLCγ2 | BMMs (ICR mice) | N/A | 5–30 μM | N/A | Park et al. (2021) |
BA | Attenuated the phosphorylation of PLCγ2-Ca2+ signaling pathway | BMMs (ICR mice) | ICR mice | 1–10 μM | 10 mg/kg | Jeong et al. (2020a) |
Artesunate | Inhibited Ca2+ influx and decreased the expression of PP2B-Aα (calcineurin) and pPLCγ1 | RAW264.7 cell | ICR mice | 3.125–12.5 μM | 10 mg/kg | Zeng et al. (2020) |
Berberine hydrochloride | Reduced the expression of Ca2+-regulated phosphatase and PLCγ | RAW264.7 cell | N/A | 5–20 μM | N/A | Ye et al. (2017) |
Methyl gallate | Blocked the Akt and Btk-PLCγ2-Ca2+ signaling | BMMs (ICR mice) | ICR mice | 1–10 μM | 10 mg/kg | Baek et al. (2017) |